Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative pain and early cognitive function in elderly thoracic surgery
ChiCTR2200065266Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain and post-operative cognitive decline (POCD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Mini-Mental State Examination. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painpost-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2200065266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065266.